Gene Teams are on the Field: Evaluation of Variants in Gene-Networks Using High Dimensional Modelling
This addresses the need for more accurate disease status prediction in medical genetics by moving beyond single-variant analysis, though it is incremental as it applies existing methods to gene networks.
The paper tackled the problem of evaluating genetic variants in complex diseases by analyzing combinations within gene networks rather than individual variants, achieving over 96% and 99% classification accuracies for mTOR and TGF-Beta networks using limited training samples.
In medical genetics, each genetic variant is evaluated as an independent entity regarding its clinical importance. However, in most complex diseases, variant combinations in specific gene networks, rather than the presence of a particular single variant, predominates. In the case of complex diseases, disease status can be evaluated by considering the success level of a team of specific variants. We propose a high dimensional modelling based method to analyse all the variants in a gene network together. To evaluate our method, we selected two gene networks, mTOR and TGF-Beta. For each pathway, we generated 400 control and 400 patient group samples. mTOR and TGF-? pathways contain 31 and 93 genes of varying sizes, respectively. We produced Chaos Game Representation images for each gene sequence to obtain 2-D binary patterns. These patterns were arranged in succession, and a 3-D tensor structure was achieved for each gene network. Features for each data sample were acquired by exploiting Enhanced Multivariance Products Representation to 3-D data. Features were split as training and testing vectors. Training vectors were employed to train a Support Vector Machines classification model. We achieved more than 96% and 99% classification accuracies for mTOR and TGF-Beta networks, respectively, using a limited amount of training samples.